e-learning
resources
Vienna 2012
Monday, 03.09.2012
Monitoring of airway diseases: far from the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Collagen degradation profile in serum of patients with COPD or IPF
F. Genovese, J. Sand, M. Nielsen, F. J. Martinez, C.M. Hogaboam, M- Han, M. Karsdal, D. Leeming (Herlev, Denmark)
Source:
Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Session:
Monitoring of airway diseases: far from the airways
Session type:
Oral Presentation
Number:
1838
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Genovese, J. Sand, M. Nielsen, F. J. Martinez, C.M. Hogaboam, M- Han, M. Karsdal, D. Leeming (Herlev, Denmark). Collagen degradation profile in serum of patients with COPD or IPF. Eur Respir J 2012; 40: Suppl. 56, 1838
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The dynamics of IV-type collagen contents in BALF of patients with COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Serological detection of elastin fragments in COPD and IPF patients
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Increased levels of osteopontin in sputum supernatant in patients with COPD
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Altered kinetics of TGFβ receptor II expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 224s
Year: 2005
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Changes of urotensin II in induced sputum and plasma of patients with COPD and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006
Cytokine and protein profile in BAL from patients with sarcoidosis and IPF
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept